National Institutes of Health: Neoplasms trials

The registry lists 377 Neoplasms studies with National Institutes of Health as lead sponsor. 36 are open to participants now and 81 have results posted.

Early Phase 1 3Phase 1 197Phase 2 99Phase 3 4Phase 4 1No phase 96(a study in two phases counts in both)

Studies

Page 4 of 4. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00030368Phase 1
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
• 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedNCT00030095Phase 1
• BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00028561Phase 1
• Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00027898Phase 1
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney FailureCompletedNCT00026169Phase 1
• SU6668 in Treating Patients With Advanced Solid TumorsCompletedNCT00024206Phase 1
• EMD 121974 in Treating Patients With Advanced Solid TumorsCompletedNCT00022113Phase 1
• Bortezomib in Treating Children With Advanced Solid TumorsCompletedNCT00021216Phase 1
• Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
• Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00019656Phase 1
• Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
• Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis TherapyCompletedNCT00019565Phase 1
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Vaccine Therapy in Treating Patients With Multiple MyelomaCompletedNCT00019097Phase 2
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasCompletedNCT00019019Phase 1
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal MethotrexateCompletedNCT00018967Not applicable
• KRN5500 in Treating Patients With Solid TumorsCompletedNCT00017238Phase 1
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid TumorsTerminatedNCT00012194Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid TumorsCompletedNCT00007917Phase 1
• Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00007878Phase 1
• BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNCT00006242Phase 1
• SU5416 and Carboplatin to Treat Ovarian CancerCompletedNCT00006155Phase 1
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00006102Phase 2
• BMS-214662 in Treating Patients With Solid TumorsCompletedNCT00005973Phase 1
• Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial NeoplasiaTerminatedNCT00005808Phase 1
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Gemcitabine in Treating Children With Refractory Solid TumorsCompletedNCT00005577Phase 1
• Prospective Study of Health in Runners and WalkersCompletedNCT00005494
• Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNCT00004988Phase 1
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004919Phase 1
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004242Phase 1
• Endostatin in Treating Patients With Advanced Solid TumorsCompletedNCT00004229Phase 1
• Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004079Phase 1
• Irofulven in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003370Phase 1
• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid TumorsCompletedNCT00003288Phase 1
• Microarray Analysis for Human Genetic DiseaseCompletedNCT00001898
• Oxaliplatin in Cancer Patients With Impaired Kidney FunctionCompletedNCT00001835Phase 1
• Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of SamplesCompletedNCT00001814
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
• HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological MalignanciesCompletedNCT00001748Phase 1
• Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseCompletedNCT00001685Phase 2
• Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668
• The Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemCompletedNCT00001603
• A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the LiverCompletedNCT00001587Phase 1
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the LiverCompletedNCT00001576Phase 1
• A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of OrganochlorinesCompletedNCT00001571
• A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal CancerCompletedNCT00001570Phase 1
• Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast CancerCompletedNCT00001507Phase 1
• Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast CancerCompletedNCT00001496
• A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid TumorsCompletedNCT00001495Phase 1
• Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast CancerCompletedNCT00001493Phase 2
• Outcomes of Education and Counseling for BRCA1 TestingCompletedNCT00001468
• A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory NeoplasmsCompletedNCT00001444Phase 1
• Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive ChemotherapyCompletedNCT00001440Phase 1
• A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the PancreasCompletedNCT00001431Phase 1
• Direct Injection of Alcohol for the Treatment of Spinal TumorsCompletedNCT00001417
• Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory MalignancyCompletedNCT00001387Phase 1
• Familial Prostate CancerCompletedNCT00001377
• Studies of Inherited Diseases of MetabolismCompletedNCT00001345
• A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic DiseaseCompletedNCT00001341Phase 1
• Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal CarcinomatosisCompletedNCT00001332Phase 1
• Gene Therapy for the Treatment of Brain TumorsCompletedNCT00001328Phase 1
• A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001302Phase 1
• Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and LymphomaCompletedNCT00001270Phase 1
• Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast CancerCompletedNCT00001269Phase 1
• Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized TrialCompletedNCT00001250Phase 2
• A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast CancerCompletedNCT00001193Phase 2
• Evaluation of Factors in Human Brain TumorsCompletedNCT00001171
• Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT00001167
• Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the PancreasCompletedNCT00001165Phase 2
• Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of CancerActive, not recruitingNCT00001163
• Women's Health Initiative (WHI)CompletedNCT00000611Phase 3